Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed vs 5-fluorouracil with Cisplatin and IMRT in HNSCC
NCT02485548Phase 3Unknown
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltitrexed in head and neck squamous cell carcinoma (HNSCC), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Status: unknown.
02
Drugs
raltitrexed
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02485548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485548.